A detailed technical and ethical guide for researchers contributing to the Journal of Hematology and Oncology Research.
Advancing Global Clinical Evidence
Journal of Hematology and Oncology Research (JHOR) 2372-6601 is an international, peer-reviewed, open-access journal dedicated to the swift publication of high-impact research across the full spectrum of hematology and oncology.
We welcome submissions from clinicians, researchers, and pharmaceutical professionals that define the next generation of cancer therapies and diagnostic innovations.
Authors should choose the submission channel that best aligns with their technical requirements and institutional policies. JHOR provides seamless integration across multi-device platforms.
Manuscript Zone
Our flagship editorial management system. It provides a robust interface for multi-file uploads, real-time tracking of peer-review milestones, and direct communication with Guest Editors.
Login to Manuscript Zone →Simplified Submission
A streamlined, mobile-optimized form designed for efficient submissions without the need for initial account registration. Ideal for rapid communications and case images.
Access Simple Form →Direct Email
Direct attachment submission to our central editorial office. Once received, your manuscript will be assigned a unique acknowledgment ID within 72 hours.
[email protected] →Scientific clarity is established through logical organization. Manuscripts must be stand-alone works that present clinical evidence without dependency on external supplemental data for core conclusions.
- Article Title: Must be descriptive, concise (max 30 words), and relevant. Avoid non-standard abbreviations that may hinder electronic indexing.
- Complete Author Metadata: Full names, physical addresses, phone numbers, and discipline. Explicitly identify the Corresponding Author, whose address will remain the primary contact point throughout the pre- and post-publication lifecycle.
- Running Title: A short header (max 60 characters) to be displayed atop printed pages.
- Keywords: 5 to 12 strategically chosen terms. Effective keywords improve discoverability in major clinical databases (PubMed, Scopus, etc.).
- Abstract: Maximum 250 words. A single, non-subheaded paragraph providing a concise summary of research objectives, methodologies, statistical results, and clinical significance.
Introduction (Max 500 words)
Briefly state the research objectives and provide sufficient background to clarify why the study was undertaken. It should clearly define the clinical gap being addressed and the specific hypotheses tested.
Materials & Methods (Technical Depth)
Provide brief but sufficiently complete information to permit a qualified reader to replicate the experiments. Cite established procedures via references; only truly innovative modifications should be detailed. Clearly state the gender of subjects and list all companies/suppliers for materials used.
Results
Present experimental findings precisely. Include only results essential to establishing the core point of the work. All numerical data must be analyzed using appropriate, robust statistical tests.
Discussion & Speculation
Maximum 1500 words. interpret findings in light of related published work. Spectulations are permitted but must be clearly identified as such and grounded in the presented evidence.
- Conclusion: Summarize principal findings within a realistic clinical framework. Assess potential applications in political, social, or technical arenas where relevant.
- Acknowledgments: Identify all funding sources (grants, institutional support). Acknowledge technical assistance from individuals who do not meet authorship criteria, ensuring they have consented to the recognition.
- Conflict of Interest (COI): Authors must disclose any associations—consultancies, financial interests, or intellectual property rights—that represent a potential conflict. A footnote may be added to the final publication if necessary.
- Supplemental Data: While manuscripts must be stand-alone, additional data (videos, large tables) may be submitted. These undergo the same rigorous peer review and will be published online only if they substantially contribute to the work.
| Technical Node | Standard Specification |
|---|---|
| References | Numbered consecutively by appearance. List first five authors, then "et al." Accuracy is the author's responsibility. Include DOI links for all clinical citations. |
| Footnotes | Used for unpublished observations or personal communications. Authors must provide written approval from any individual cited in a footnote. |
| Tables & Legends | Submit each table on a separate page at the end of the manuscript. Titles and legends must provide sufficient detail for the table to stand alone. |
| Figures & Art | High-resolution files required. Symbols and text must be no smaller than 2mm after reduction. Legends must be placed immediately below the figure. |
| Abbreviations | Must be defined in a single consolidated footnote immediately after the first abbreviation is cited in the main text. |
JHOR enforces the highest standards of integrity. We align with the Committee on Publication Ethics (COPE) and the ICMJE to maintain zero tolerance for malpractice.
Human Subjects
Obtain informed consent only after full disclosure of potential outcomes. Maintain strict confidentiality. Never influence participants through disproportionate rewards for participation.
Animal Research
Experiments must comply with international Care and Use rules. Precautionary ethical measures and institutional approvals must be explicitly documented in the Methods section.
Scientific Truth
Plagiarism, scientific fraud, and duplicate submissions are considered serious misconduct. JHOR reserves the right to notify institutional boards if such breaches are identified.
JHOR accepts a wide variety of manuscript styles to accommodate different research depths:
- Primary Research: Original Research Papers, Clinical Trials, Methodological Innovations.
- Reviews: Comprehensive Reviews, Literature Reviews, Mini-Reviews, Book Reviews.
- Rapid Feedback: Rapid Communications, Letters to the Editor, Editorials, Commentaries.
- Case Evidence: Case Reports, High-Resolution Case Images.
- Academic: Thesis Overviews, Conference Proceedings, Perspectives, Opinions.
Publish Your Clinical Breakthrough
Your research has the power to change clinical practice. Follow these guidelines to ensure a smooth, professional submission process.
Advancing clinical truth through excellence. Last updated: January 2026.
Public Access and Funder Compliance
Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.
What JHOR provides: JHOR publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.
Author responsibility: JHOR does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.
Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.
Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JHOR is indexed in MEDLINE, included in the PMC Journal List or that all JHOR articles are available through PubMed. The journal's current coverage is listed on the Indexing page.
Collaborated Universities
- Rivers State University
- Azuonwu Obioma, Somba Nyenwere
- Investigation of Antimicrobial Activity of the Extracts of the Leaves, Stembark and Root of Allanblackia floribunda: An Alternative Paradigm Shift Outcome.
- Liaquat University of Medical and Health Sciences Jamshoro
- Ashique Ali Arain, Syed Muhammad Ali, Madiha Shah
- Vitamin -D Deficiency: A Clinical Problem Searching For Solution.
Recent Articles
Other Relevant journals
Brain And Spinal Cancer
ISSN : 2576-182XA brain tumor is an abnormal growth of tissue in the brain or central spine that can disrupt proper brain function. Doct...
Breast Cancer Survival
Breast cancer is the most common invasive cancer in females worldwide. It accounts for 16% of all female cancers and 22....
Thyroid Cancer
ISSN : 2574-4496Most nodules are cysts filled with fluid or with a stored form of thyroid hormone called colloid. Solid nodules have lit...
Lung Cancer Epidemiology
Lung cancer is uncontrolled growth of abnormal cells that start off in one or both lungs; usually in the cells that line...
Editor in chief
